Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)

NCT01888835 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Amphetamine-Related Disorders

Interventions

DRUG: Mirtazapine
DRUG: Placebo

Sponsor

Phillip Coffin, MD, MIA

Collaborators

[object Object]